Back to mobile site

Watson (WPI) Gets FDA Approval for Generic Sanctura XR (AGN)

October 12, 2012 4:06 PM EDT Send to a Friend
Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its subsidiary Watson Laboratories, Inc. – Florida has received approval from the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login